We equip customers with key advantages through nanolithography solutions
We equip customers with key advantages through nanolithography solutions
Explore Nanolithography
Is this where your Obducat story begins? We are currently looking for new talents
Do you enjoy an international work environment and seek to drive change? Are you passionate about nanotechnology, sales, engineering and consider yourself to be a contributing team player? Check out our job opportunities below.
Sorrento Therapeutics highlights the Sofusa® Drug Delivery System in Covid-19 Vaccine Development program
The Sofusa® Drug Delivery System, for which Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles, was highlighted in Sorrento Therapeutics proprietary mRNA vaccine development program for COVID-19.
Obducat customer Sorrento Therapeutics reports positive results
Sorrento Therapeutics, a biopharmaceutical company, reports positive initial result in dosing with the Sofusa® Lymphatic Drug Delivery Device. Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles used in the Sofusa® Drug Delivery System.
Obducat is an innovative developer and world-leading supplier of micro-and nano lithography solutions. We supply the technology, products and processes used for advanced micro- and nanopatterning of surfaces.
Upcoming events
SPIE. Photonics West
January 25-27, 2022
San Francisco, USA
Visit us there!
http://www.spie.org
Press Release
Obducat and Neutronix Quintel (NXQ) Announce Collaboration Agreement
OBDUCAT AB (publ), a leading supplier of lithography processing solutions and nanoimprint lithography (NIL) tools, has entered into collaboration agreement with Neutronix Quintel (NXQ), a world-renowned US-based supplier of mask aligners & photolithography systems. Obducat and NXQ have had a longstanding relationship and mutual technological respect, and this agreement marks the start of a more…
Read more